Skip to content

Drug interactions

Carfilzomib + Etrasimod

Severity: Major

Carfilzomib and Etrasimod: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Etrasimod reduces circulating lymphocytes and carfilzomib is immunosuppressive and myelosuppressive. Together they may increase infection risk. The combination has not been studied.

What this interaction means in plain words

Carfilzomib and Etrasimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Carfilzomib belongs to Oncology; Etrasimod belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Additive immunosuppression from S1P receptor modulation and proteasome inhibition.

What to do

Avoid concurrent use where possible. If it is needed, monitor for infection and lymphocyte counts.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Carfilzomib and Etrasimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Carfilzomib with Etrasimod?

MediHelp rates the interaction as major. Carfilzomib and Etrasimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Etrasimod reduces circulating lymphocytes and carfilzomib is immunosuppressive and myelosuppressive. Together they may increase infection risk. The combination has not been studied.

How serious is the interaction between Carfilzomib and Etrasimod?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible. If it is needed, monitor for infection and lymphocyte counts.

What other medicines interact with Carfilzomib?

MediHelp also lists interactions of Carfilzomib with, for example, Ropeginterferon alfa 2b, Dichlorphenamide, Palifermin. The full list is on the Carfilzomib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in